Ginsenoside Rh<sub>3</sub> enhances regorafenib efficacy in hepatocellular carcinoma by modulating FGFR4-STAT3-YAP signaling pathway.
- DOI
- 10.1016/j.bcp.2026.117679
- Published
- 2026-01-05
- Container
- Biochem Pharmacol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.117679,
title = {Ginsenoside Rh\<sub\>3\</sub\> enhances regorafenib efficacy in hepatocellular carcinoma by modulating FGFR4-STAT3-YAP signaling pathway.},
author = {Jeon Y and Kwon H and Yoo JE and Park K and Chung T and Park YN and Sim J and Kim T and Ham J and Kim YJ.},
year = {2026},
journal = {Biochem Pharmacol},
doi = {10.1016/j.bcp.2026.117679},
url = {https://doi.org/10.1016/j.bcp.2026.117679}
}RIS
TY - JOUR TI - Ginsenoside Rh<sub>3</sub> enhances regorafenib efficacy in hepatocellular carcinoma by modulating FGFR4-STAT3-YAP signaling pathway. AU - Jeon Y AU - Kwon H AU - Yoo JE AU - Park K AU - Chung T AU - Park YN AU - Sim J AU - Kim T AU - Ham J AU - Kim YJ. PY - 2026 JO - Biochem Pharmacol DO - 10.1016/j.bcp.2026.117679 UR - https://doi.org/10.1016/j.bcp.2026.117679 ER -
APA
Y, J., H, K., JE, Y., K, P., T, C., YN, P., J, S., T, K., J, H., & YJ., K. (2026). Ginsenoside Rh<sub>3</sub> enhances regorafenib efficacy in hepatocellular carcinoma by modulating FGFR4-STAT3-YAP signaling pathway.. Biochem Pharmacol. https://doi.org/10.1016/j.bcp.2026.117679
Source records
- europe-pmc · retrieved 2026-09-25T07:49:25.755Z